Market Overview - The Shanghai Composite Index increased by 0.47% as of the morning close, with a trading volume of 878.04 million shares and a total transaction value of 13,271.58 billion yuan, representing a decrease of 7.25% compared to the previous trading day [1]. Sector Performance - The sectors with the highest gains included: - Comprehensive: 4.13% increase with a transaction value of 21.50 billion yuan, led by Dongyangguang with a 10.01% rise [1]. - Building Materials: 3.15% increase with a transaction value of 158.25 billion yuan, led by International Composite Materials with a 19.92% rise [1]. - Electric Equipment: 2.78% increase with a transaction value of 1,319.95 billion yuan, led by Oulu Tong with a 17.65% rise [1]. - The sectors with the largest declines included: - Banking: 1.96% decrease with a transaction value of 313.94 billion yuan, led by CITIC Bank with a 3.14% drop [1]. - Food and Beverage: 0.06% decrease with a transaction value of 174.29 billion yuan, led by Guifaxiang with a 5.39% drop [1]. Notable Stocks - Top-performing stocks included: - Dongyangguang in the Comprehensive sector with a 10.01% increase [1]. - International Composite Materials in Building Materials with a 19.92% increase [1]. - Oulu Tong in Electric Equipment with a 17.65% increase [1]. - Underperforming stocks included: - CITIC Bank in the Banking sector with a 3.14% decrease [1]. - Guifaxiang in Food and Beverage with a 5.39% decrease [1].

| 申万行业 | 行业涨跌（%） | 成交额（亿元） | 比上日（%） | 领涨（跌）股 | 涨跌幅（%） | | --- | --- | --- | --- | --- | --- | | 综合 | 3.91 | 18.41 | 21.27 | 东阳光 | 10.01 | | 建筑材料 | 2.69 | 122.00 | -3.56 | 国际复材 | 19.92 | | 房地产 | 1.77 | 139.31 | -4.43 | 衢州发展 | 10.04 | | 机械设备 | 1.53 | 820.43 | -7.68 | 海能技术 | 29.97 | | 电子 | 1.38 | 1277.44 | -28.34 | 中富电路 | 20.01 | | 电力设备 | 1.29 | 809.02 | 8.65 | 欧陆通 | 14.30 | | 基础化工 | 1.25 | 454.72 | -6.62 | 硅烷科技 | 14.66 | | 汽车 | 1.22 | 494.98 | -9.44 | 川环科技 | 20.00 | | 有色金属 | 1.21 | 474.29 | 5.88 | 金田股份 | 10.0 ...

Group 1 - The core viewpoint of the article highlights the financial performance of HaiNeng Technology in the first half of the year, reporting a revenue of 136 million yuan, which represents a year-on-year growth of 34.87% [1] - The net profit attributable to the shareholders of the parent company reached 5.4715 million yuan, showing a significant year-on-year increase of 139.03% [1] Group 2 - On August 13, the Shanghai Stock Exchange disclosed that Guangzhou Hexin Instrument Co., Ltd. has submitted a draft report for an asset acquisition and fundraising through a share issuance and cash payment, which has been officially accepted [2] - Hexin Instrument plans to acquire 56.00% equity of Liangxi Technology from two transaction parties, Wu Ming and Shanghai Yandao, and aims to raise no more than 246.4 million yuan in supporting funds [2]

Investment Rating - The report maintains an "Outperform" rating for the company [7]. Core Views - The company reported strong growth in its 2025 half-year results, with revenue reaching 136 million yuan, a year-on-year increase of 34.9%, and a net profit of 5 million yuan, up 139.0% year-on-year [4][7]. - The growth is driven by all four major product lines, particularly the "Spectroscopy Series," which saw a revenue increase of 61.7% [7]. - The company is expected to benefit from ongoing equipment replacement demands and favorable industry conditions, particularly in the spectroscopy segment, which is anticipated to become a new growth engine [7]. Financial Data and Profit Forecast - The company’s total revenue is projected to be 378 million yuan in 2025, with a year-on-year growth rate of 21.9% [6]. - The net profit forecast for 2025 is 51 million yuan, reflecting a significant increase of 290.8% compared to the previous year [6]. - The gross profit margin is expected to improve to 66.8% by 2025, indicating a positive trend in profitability [6]. Revenue and Profit Analysis - In the first half of 2025, the company achieved a gross profit margin of 63.6%, an increase of 0.9 percentage points year-on-year [7]. - The company has successfully reduced its expense ratios, with significant decreases in sales, management, and R&D expense ratios [7]. - The company is focusing on expanding its enterprise customer base, which now accounts for over 50% of its revenue, enhancing its operational resilience [7].

投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 □特定对象调研 证券代码：430476 证券简称：海能技术 公告编号：2025-122 海能未来技术集团股份有限公司 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 （线上会议） 二、 投资者关系活动情况 活动时间：2025 年 8 月 13 日至 2025 年 8 月 14 日 活动地点：线上调研 参会单位及人员：2025 年 8 月 13 日：华源证券、南方基金、中信建投基金、 同泰基金、西部利得基金、中泰资管、开源证券、万和证券、联储证券、民生证 券、中泰证券、爱建证券、财信证券、国泰海通、上海易正朗投资管理有限公司、 张家港高竹私募基金管理有限公司、深圳市国晖投资有限公司、深圳市泰石投资 管理有限公司、上海益理资产管理有限公司、上海景领投资管理有限公司、上海 滦海投资管理有限公司、华夏未来资本管理有限公司、深圳市尚诚资产管理有限 责任公司、上海行知创投、深圳市兰权 ...

Core Viewpoint - In the first half of 2025, Haineng Technology reported a revenue of 136 million yuan, a year-on-year increase of 34.87%, and a net profit attributable to shareholders of 5.4715 million yuan, up 139.03% [2][3]. Group 1: Revenue Growth and Product Lines - The main business revenue of Haineng Technology grew by 34.56% compared to the same period last year, driven by the results of previous R&D and market investments, as well as the effectiveness of a diversified product strategy [5]. - All four major product lines (organic element analysis, sample pretreatment, chromatography and spectroscopy, general instruments) achieved revenue growth [5]. - The organic element analysis segment saw a revenue increase of 25.62%, while the chromatography and spectroscopy segment experienced a significant revenue growth of 61.71% [8][9]. Group 2: Domestic and International Business - In the first half of 2025, domestic revenue accounted for 77.04% of total revenue, while international revenue made up 22.96%, with overseas revenue increasing by 22.49% year-on-year [11]. - Haineng Technology has actively expanded its overseas market through international dealer conferences and exhibitions, with products sold in over 130 countries and regions [11]. Group 3: Policy and Market Opportunities - The Chinese government has introduced significant policies in key areas such as pharmaceutical health, energy transition, marine economy, and ecological environment governance, providing broad market opportunities for the scientific instrument industry [12][13][14][15][16]. - Haineng Technology's products are well-positioned to support the pharmaceutical industry, energy sector, and marine economy, contributing to national energy security and low-carbon transition [13][14][15]. Group 4: Strategic Developments and Innovations - In March 2025, Haineng Technology signed a cooperation agreement with Xi'an Jiaotong University to establish a research institute for intelligent analysis instruments, which could enhance the company's product offerings and competitiveness [17]. - The company is developing an instrument control system based on the domestic "Hongmeng system" to align with national strategies for independent innovation and data security [17]. - A project to build an intelligent manufacturing base for scientific instruments with an investment of up to 230 million yuan has been approved, aimed at attracting international talent and enhancing product and technology autonomy [18].

Group 1 - The core viewpoint of the article highlights the growth in the instrument manufacturing industry in China, with an increase in the number of enterprises and a positive year-on-year growth rate [1][3] - As of the first half of 2025, there are 7,645 instrument manufacturing enterprises, which is an increase of 441 compared to the same period last year, representing a year-on-year growth of 6.12% [1] - The proportion of instrument manufacturing enterprises in the total number of industrial enterprises is 1.47% [1] Group 2 - The article references a report by Zhiyan Consulting titled "2025-2031 China Instrument and Meter Market Supply and Demand Forecast and Future Development Trend Report" [1] - The data mentioned in the article is sourced from the National Bureau of Statistics and organized by Zhiyan Consulting [3]

Group 1: Macro Insights - The credit data for July shows a rare negative turn, with new credit scale turning negative for the first time in 20 years, while social financing continues to grow under government bond support [4] - M1 growth has increased for two consecutive months, indicating faster fund activation in both resident and corporate sectors, particularly driven by a rise in resident demand [4] - The overall monetary policy is expected to remain loose, with potential for further rate cuts and reductions in reserve requirements due to economic downward pressure [4] Group 2: Company Insights - 卓胜微 (Zhuosheng Micro) - The company is advancing its chip project, with significant production capacity achieved in both 6-inch and 12-inch wafer production lines, indicating a strong position in the RF front-end market [8][9] - Revenue projections for 2025, 2026, and 2027 are estimated at 4.91 billion, 5.61 billion, and 6.67 billion CNY respectively, with corresponding net profits of 380 million, 860 million, and 1.29 billion CNY [9] Group 3: Company Insights - 万国黄金 (Wanguo Gold) - The company holds three significant mining assets, including the world-class Jinling Gold Mine, which is expected to contribute significantly to future revenue growth [10][12] - Revenue forecasts for 2025, 2026, and 2027 are projected at 3.49 billion, 4.77 billion, and 5.36 billion CNY, with net profits of 1.41 billion, 1.87 billion, and 2.18 billion CNY respectively [12] Group 4: Company Insights - 海能技术 (Haineng Technology) - The company reported a strong revenue growth of 34.9% year-on-year for H1 2025, reaching 140 million CNY, with a net profit increase of 139% [13] Group 5: Company Insights - 中科三环 (Zhongke Sanhuan) - The company achieved a net profit of 44 million CNY in H1 2025, marking a turnaround from losses, with a significant reduction in expense ratios contributing to improved profitability [14][15] - Future profit projections for 2025, 2026, and 2027 are estimated at 170 million, 250 million, and 350 million CNY respectively [15] Group 6: Company Insights - 奥比中光 (Obi Zhongguang) - The company is focusing on the robotics sector, with a projected revenue growth of 65.9%, 57.6%, and 28.6% for 2025, 2026, and 2027 respectively [16] Group 7: Company Insights - 鹏鼎控股 (Pengding Holdings) - The company reported a revenue of 16.38 billion CNY for H1 2025, a year-on-year increase of 24.8%, with a net profit growth of 57.2% [17][18] - Future revenue projections for 2025, 2026, and 2027 are expected to be 41.2 billion, 48.3 billion, and 55.6 billion CNY respectively [18] Group 8: Company Insights - 甘源食品 (Ganyuan Food) - The company experienced a revenue decline of 9.3% year-on-year for H1 2025, with net profits down by 55.2%, indicating challenges in channel adjustments [20] Group 9: Company Insights - 361度 (361 Degrees) - The company achieved a revenue growth of 11% year-on-year for H1 2025, with a net profit increase of 8.6% [21][22] - Future profit projections for 2025, 2026, and 2027 are estimated at 1.261 billion, 1.420 billion, and 1.588 billion CNY respectively [22]

Core Viewpoint - Haineng Technology reported a significant increase in revenue and profitability in its 2025 semi-annual report, reflecting a positive trend in the domestic scientific instrument industry and the company's strategic initiatives in technology development and collaboration [1][4]. Financial Performance - The company achieved operating revenue of 136.07 million yuan, a year-on-year increase of 34.87% [2] - The net profit attributable to shareholders was 5.47 million yuan, marking a turnaround from a loss of 14.02 million yuan in the previous year, representing a 139.03% improvement [2] - The gross profit margin was 63.60%, slightly up from 62.69% in the previous year [2] - Basic earnings per share increased to 0.07 yuan from a loss of 0.17 yuan, a 141.18% improvement [2] Strategic Initiatives - The company is developing an instrument control system based on the domestic "Hongmeng System" to align with the trend of replacing imported instruments with domestic alternatives [1][5] - Haineng Technology established a large model intelligent operation department to enhance AI capabilities and integrate intelligent technology with business scenarios [6] - The company signed a cooperation agreement with Xi'an Jiaotong University to establish a research institute for intelligent analysis instruments, focusing on innovative technologies for pharmaceutical and environmental applications [5] Research and Development - R&D investment has consistently increased over the past eight years, with a compound annual growth rate of 20.85%, and R&D expenditure has accounted for over 15% of operating revenue in the last three years [4] - The company holds 53 invention patents, 131 utility model patents, and 91 software copyrights, with 41 invention patent applications currently under review [4] Infrastructure Development - Haineng Technology plans to invest up to 230 million yuan in the construction of an intelligent manufacturing base for scientific instruments in Shanghai, aiming to attract top talent and enhance product and technology autonomy [7] - The project will incorporate digital, intelligent, and green manufacturing processes, including the establishment of an industrial internet platform and smart warehousing systems [7]

Company and Industry Summary Company Overview - **Company Name**: Haineng Technology - **Reporting Period**: First half of 2025 Key Financial Performance - **Net Profit**: Achieved a net profit attributable to shareholders of 5.47 million, with a growth rate exceeding 100% [2][3] - **Net Profit Excluding Non-recurring Items**: Reached 1.21 million, also showing over 100% growth [2][3] - **Revenue Growth**: Overall revenue increased by 4.87% year-on-year [3] - **R&D Investment**: R&D expenses amounted to 27.47 million, a year-on-year increase of 1.58%, representing 20.19% of total revenue [2][3][7] - **Gross Margin**: Gross margin stood at 63.60%, up by 0.91 percentage points from the previous year [3] Product Performance - **Chromatography and Spectroscopy Products**: - Revenue growth of 62% in the first half of 2025, with the Wukong series nearing 18 million and Gas series exceeding 10 million [2][6] - Significant demand from pet feed, energy, and pharmaceutical sectors [2][6] - **High-Performance Liquid Chromatography (HPLC)**: - Achieved over 60% growth, driven by orders from major pharmaceutical clients like Qilu Pharmaceutical [9] - **Energy Sector**: - Notable performance with a doubling of revenue, particularly from Gas products used in landfill power generation [10] Market Dynamics - **Industry Recovery**: Signs of recovery in food, pharmaceutical, and energy sectors, despite overall weak demand [4][5] - **Future Outlook**: - Optimistic projections for new products with expected annual growth rates of 35% to 50% [4][11] - Anticipation of continued growth in the domestic market for Gas products, projected at 30% to 40% [13] Strategic Initiatives - **R&D Focus**: Continuous investment in R&D to enhance technology and market competitiveness, crucial for long-term growth [7][33] - **Share Buyback**: No further buybacks due to stable stock prices above 15, maintaining a total buyback amount of 30.42 million [2][8] - **International Expansion**: Continued growth in overseas markets, with a 22% increase in the first half of 2025, focusing on Southeast Asia, the Middle East, and Latin America [34] Innovations and Future Products - **New Product Development**: - Collaboration with Xi'an Jiaotong University on cell membrane chromatography technology, with potential applications in drug screening [20] - Development of AI-driven software based on domestic operating systems, with several products expected to launch in 2025 [25][26][27] - **Smart Laboratory Initiatives**: Focus on automating individual testing processes, with ongoing projects in various fields [28][29] Operational Efficiency - **Cost Management**: Decrease in sales and management expense ratios due to revenue growth outpacing expense increases [31][32] - **Manufacturing Base**: Construction of the Shanghai Songjiang intelligent manufacturing base aimed at creating a leading factory in the industry, with a projected annual output value of 1 billion [30] Conclusion - Haineng Technology is positioned for significant growth driven by strong product performance, strategic R&D investments, and a focus on market recovery across key sectors. The company is optimistic about future performance and continues to explore innovative solutions to enhance its competitive edge in the scientific instrument industry.